Fundraising Fox

Ametris

1 known investors

ametris.com ↗

Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical Devicesin /ametrisdigitalhealth

Investors · 1

ARCHIMED JapanLyon · $10.8M – $1.1B

Competitors · 1

by search overlap
Massdevice44 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.

Companies competing with Ametris for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Ametris do?
Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.
Who are Ametris's investors?
Ametris's investors include ARCHIMED Japan.